DK0527757T3 - Sammensætning og fremgangsmåde til behandling af akne vulgaris og forsinkelse af ældning - Google Patents

Sammensætning og fremgangsmåde til behandling af akne vulgaris og forsinkelse af ældning

Info

Publication number
DK0527757T3
DK0527757T3 DK91906989.8T DK91906989T DK0527757T3 DK 0527757 T3 DK0527757 T3 DK 0527757T3 DK 91906989 T DK91906989 T DK 91906989T DK 0527757 T3 DK0527757 T3 DK 0527757T3
Authority
DK
Denmark
Prior art keywords
acne vulgaris
composition
treating acne
delaying aging
derivative
Prior art date
Application number
DK91906989.8T
Other languages
English (en)
Inventor
Lit-Hung Leung
Original Assignee
Leung Lit Hung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leung Lit Hung filed Critical Leung Lit Hung
Application granted granted Critical
Publication of DK0527757T3 publication Critical patent/DK0527757T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91906989.8T 1990-03-27 1991-03-27 Sammensætning og fremgangsmåde til behandling af akne vulgaris og forsinkelse af ældning DK0527757T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909006785A GB9006785D0 (en) 1990-03-27 1990-03-27 Composition and methods for treatment of acne vulgaris and retardation of ageing

Publications (1)

Publication Number Publication Date
DK0527757T3 true DK0527757T3 (da) 1998-01-19

Family

ID=10673309

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91906989.8T DK0527757T3 (da) 1990-03-27 1991-03-27 Sammensætning og fremgangsmåde til behandling af akne vulgaris og forsinkelse af ældning

Country Status (13)

Country Link
US (2) US5459153A (da)
EP (1) EP0527757B1 (da)
JP (1) JP3409127B2 (da)
AT (1) ATE154879T1 (da)
AU (1) AU654812B2 (da)
CA (1) CA2078670C (da)
DE (1) DE69126703T2 (da)
DK (1) DK0527757T3 (da)
ES (1) ES2106076T3 (da)
GB (1) GB9006785D0 (da)
GR (1) GR3024544T3 (da)
HK (1) HK1001185A1 (da)
WO (1) WO1991014431A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364885A (en) * 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
DE4328871A1 (de) * 1993-08-27 1995-03-02 Beiersdorf Ag Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis
US5616617A (en) * 1995-11-27 1997-04-01 Van Moerkerken; Arthur Face pimples prevention method and compositions
US5833998A (en) * 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
US5939082A (en) * 1995-11-06 1999-08-17 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
US6238678B1 (en) 1995-11-06 2001-05-29 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
JPH11508281A (ja) * 1996-04-23 1999-07-21 ザ、プロクター、エンド、ギャンブル、カンパニー ビタミンｂ▲下３▼化合物による皮膚外観の調整方法
USH2013H1 (en) 1997-05-23 2002-02-05 The Procter & Gamble Company Skin care compositions
US5968528A (en) * 1997-05-23 1999-10-19 The Procter & Gamble Company Skin care compositions
WO1999047113A1 (en) * 1998-03-16 1999-09-23 The Procter & Gamble Company Compositions for regulating skin appearance
FR2780888B1 (fr) * 1998-07-09 2000-10-13 Benac Lotion nettoyante et traitante destinee au traitement des comedons
AU5686799A (en) * 1998-08-27 2000-03-21 Procter & Gamble Company, The Methods of reducing the irritation associated with vitamin b3 compositions
PT1143954E (pt) * 1998-12-01 2004-12-31 Univ Kentucky Res Found Utilizacao de derivados de acido nocotinico para o tratamento de danos no adn em celulas da pele
US6444647B1 (en) 1999-04-19 2002-09-03 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US6979468B1 (en) 2002-12-06 2005-12-27 Sirius Laboratories Oral composition and method for the treatment of inflammatory cutaneous disorders
US20050048012A1 (en) * 2003-08-26 2005-03-03 Roland Jermann Use of biotin or a biotin derivative for skin lightening purposes and for the treatment of senile lentigines
JP5338030B2 (ja) * 2007-01-31 2013-11-13 大正製薬株式会社 アダパレン含有外用剤組成物
US20100068334A1 (en) * 2008-09-12 2010-03-18 Damon Randolph Race Medicinal Food and Beverage Compositions and Related Methods for Managing Acne in Humans

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
US4885157A (en) * 1987-02-13 1989-12-05 Fiaschetti Mary G Dermal cosmetic composition and applications therefor
LU87145A1 (fr) * 1988-02-26 1989-09-20 Oreal Methode pour ameliorer l'aspect esthetique de la peau a l'aide de melanges polyvitaminiques
US4857321A (en) * 1988-08-26 1989-08-15 Thomas William C Skin ointment

Also Published As

Publication number Publication date
AU7565891A (en) 1991-10-21
DE69126703D1 (de) 1997-08-07
ES2106076T3 (es) 1997-11-01
DE69126703T2 (de) 1998-02-05
AU654812B2 (en) 1994-11-24
GB9006785D0 (en) 1990-05-23
US5519039A (en) 1996-05-21
US5459153A (en) 1995-10-17
HK1001185A1 (en) 1998-05-29
JPH05505819A (ja) 1993-08-26
CA2078670A1 (en) 1991-09-28
ATE154879T1 (de) 1997-07-15
EP0527757A1 (en) 1993-02-24
WO1991014431A1 (en) 1991-10-03
JP3409127B2 (ja) 2003-05-26
CA2078670C (en) 2003-02-11
GR3024544T3 (en) 1997-12-31
EP0527757B1 (en) 1997-07-02

Similar Documents

Publication Publication Date Title
DK0527757T3 (da) Sammensætning og fremgangsmåde til behandling af akne vulgaris og forsinkelse af ældning
NZ337211A (en) Method of treating inflammatory, HIV diseases by using peptidyl boronic acid ester and acid compounds as proteasome inhibitors
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
RS49981B (sr) Upotreba derivata hidroksilamina za dobijanje farmaceutskih kompozicija korisnih za povećanje ekspresije i aktivnosti molekulskih šaperona
IL109604A0 (en) Substituted mono- and bipyridylmethyl- pyridones, process for their preparation and pharmaceutical compositions containing them
AUPR177300A0 (en) Therapeutic methods
HU9204029D0 (en) Proteolytic enzym inhibitors
AU7371600A (en) Use of alpha-linolenic acid metabolites for treatment or prevention of cancer
ZA967880B (en) Compositions and methods for inhibition of the patho-physiologic actions in mammals in tumor necrosis facto-alpha
NO953763L (no) Heterocykel-holdige amidin-derivater, deres fremstilling og anvendelse
WO1999012951A8 (en) Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
AU587054B2 (en) Novel pharmaceutical compositions intended to the treatment of neuropathies and insuring the nervous regeneration
DK166323C (da) Griseolsyrederivater og farmaceutiske midler indeholdende disse
NO933321D0 (no) Nadh og nadph som legemiddel til behandling av mobus alzheimer
WO1994005296A3 (en) Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine
DK0500953T3 (da) Potentiator af antineoplastisk virkning og antineoplastisk middel
DK0628038T3 (da) 3-Alkyloxy-, aryloxy- eller arylalkyloxy-benzo [b] - thiophen-2-carboxamider som inhibitorer af celleadhæsion
AU3523295A (en) Quinoxaline derivatives useful in therapy
DK1025101T3 (da) Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet
HU9200025D0 (en) Medical preparations for treating depression
ATE69551T1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
EP1146866A4 (en) METHOD OF TREATMENT OF ACNEEPATIENTS BY ADMINISTERING CYCLIC GMP PDE INHIBITORS
ATE150313T1 (de) Verwendung von nadh oder nadph gegen krebs oder aids